提高人类健康和寿命:一个有针对性的战略,强调他类药物
Edward Calabrese1, Peter Pressman2
1Department of Environmental Health Sciences, University of Massachusetts, Morrill I, N344, Amherst, MA, 01003, USA. edwardc@schoolph.umass.edu.
类药物在减缓与年龄相关的疾病和降低20-50%的癌症风险方面显示出显著的潜力. 进一步的研究可以探索他类药物作为一种公共卫生策略,以提高健康寿命.
科学领域:
- 老年学是一门学科.
- 药理学 药理学是指药理学的学科.
- 公共卫生 公共卫生
背景情况:
- 越来越多的人对缓解与年龄相关疾病的干预措施感兴趣.
- 类药物是促进不同人群健康的广泛研究的药物.
- 流行病学研究调查了他类药物对众多健康终点的影响.
研究的目的:
- 评估他类药物的广泛健康益处.
- 评估他类药物作为公共卫生战略的潜力.
- 探讨使用他类药物的机制和解决不良影响.
主要方法:
- 大规模的流行病学研究.
- 对细胞和动物模型的分析.
- 对拟议的基本行动机制进行审查.
主要成果:
- 立方体治疗始终可以将非传染性疾病,传染性病理和高死亡率癌症的发病率和严重程度降低20-50%.
- 来自流行病学,细胞和动物研究的证据支持他类药物的广泛有益作用.
- 激活Nrf2是一种被提议的关键机制,有助于促进他类药物的益处.
结论:
- 类药物表现出广泛的积极健康影响,影响许多疾病和癌症.
- 斯坦丁激活Nrf2的能力及其生物可用性有助于其健康益处.
- 探索他类药物作为公共卫生策略,以及对肌痛等副作用的管理是有必要的.
更多相关视频
10:56A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
Published on: September 15, 2018
09:06Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice
Published on: February 20, 2019
相关概念视频
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Targeted Cancer Therapies
There are several types of targeted therapies against...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Protein Networks
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
